Ireland - English - HPRA (Health Products Regulatory Authority)

vetoquinol uk limited - marbofloxacin, clotrimazole, dexamethasone (as dexamethasone acetate) - ear drops suspension - unknown - dexamethasone and antiinfectives - canine - antibacterial

United States - English - NLM (National Library of Medicine)

proficient rx lp - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - ciprodex is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: acute otitis media (aom) in pediatric patients (age 6 months and older) with tympanostomy tubes due to staphylococcus aureus , streptococcus pneumoniae , haemophilus influenzae , moraxella catarrhalis , and pseudomonas aeruginosa . acute otitis externa (aoe) in pediatric (age 6 months and older), adult and elderly patients due to staphylococcus aureus and pseudomonas aeruginosa . teratogenic effects. pregnancy category c: no adequate and well controlled studies with ciprodex have been performed in pregnant women. caution should be exercised when ciprodex is used by a pregnant woman. animal reproduction studies have not been conducted with ciprodex. reproduction studies with ciprofloxacin have been performed in rats and mice using oral doses of up to 100 mg/kg and intravenous (iv) doses up to 30 mg/kg, and have revealed no evidence of harm to the fetus.

United States - English - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - ciprodex® is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: - acute otitis media (aom) in pediatric patients (age 6 months and older) with tympanostomy tubes due to staphylococcus aureus , streptococcus pneumoniae , haemophilus influenzae , moraxella catarrhalis , and pseudomonas aeruginosa . - acute otitis externa (aoe) in pediatric (age 6 months and older), adult and elderly patients due to staphylococcus aureus and pseudomonas aeruginosa . - ciprodex is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to other quinolones, or to any of the components in this medication. - use of this product is contraindicated in viral infections of the external canal, including herpes simplex infections and fungal otic infections. risk summary there are no available data on ciprodex use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage or adverse ma

Kenya - English - Pharmacy and Poisons Board

ofloxacin & dexamethasone - ear/eye drops, solution - ofloxacin usp 0.3% w/v dexamethasone sodium… - ophthalmologicals: corticosteroids and

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

santen oy - dexamethasone sodium phosphate 1,32 mg/ml - eq. dexamethasone 1 mg/ml; levofloxacin hemihydrate 5,12 mg/ml - eq. levofloxacin 5 mg/ml - eye drops, solution - 1,32 mg/ml - 5 mg/ml - levofloxacin hemihydrate 5.12 mg/ml; dexamethasone sodium phosphate 1.32 mg/ml - dexamethasone and antiinfectives

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

santen pharma malaysia sdn. bhd. - dexamethasone sodium phosphate; levofloxacin hemihydrate -

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - marbofloxacin, clotrimazole, dexamethasone (as dexamethasone acetate) - ear drops suspension - 10.0/3.0 - dexamethasone and antiinfectives - canine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - marbofloxacin, clotrimazole, dexamethasone (as dexamethasone acetate) - ear drops suspension - 10.0/3.0/1 - dexamethasone and antiinfectives - canine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - marbofloxacin; clotrimazole; dexamethasone acetate - ear drops, suspension - 3, 10, 1 milligram(s)/millilitre - dexamethasone and antiinfectives - dogs - not currently available

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - dexamethasone; ciprofloxacin hydrochloride - ear drops - 1mg/1ml ; 3mg/1ml